We have previously confirmed the presence of common antigens between Schistosoma mansoni and its vector, Biomphalaria glabrata . Cross-reactive antigens may be important as possible candidates for vaccine and diagnosis of schistosomiasis. Sera from outbred mice immunized with a soluble Biomphalaria glabrata antigen ( SBg A) of non-infected B. glabrata snails recognized molecules of SBg A itself and S. mansoni AWA by Western blot. Recognition of several molecules of the SBg A were inhibited by pre-incubation with AWA (16, 30, 36, 60 and 155 kDa). The only specific molecule of AWA, inhibited by SBg A, was a 120 kDa protein. In order to determine which epitopes of SBg A were glycoproteins, the antigen was treated with sodium metaperioda...
The development of a more sensitive diagnostic test for schistosomiasis is needed to overcome the li...
INTRODUCTION: The correlation between the immunological assay and the antibody titer can offer a too...
An effective schistosome vaccine is a desirable control tool but progress towards that goal has been...
We have previously confirmed the presence of common antigens between Schistosoma mansoni and its vec...
Background: Schistosomiasis continues to be one of the most prevalent parasitic diseases in the worl...
Three antigens protective against Schistosoma mansoni have been extensively characterized. The schis...
Polypeptide surface antigens of Schistosoma mansoni recognized by schistosomiasis patients have been...
Chronic schistosomiasis is a spectral illness where patients present with either moderate intestinal...
Attempts have been made in this dissertation to develop a purified antigen with high sensitivity and...
Schistosoma japonicum affects several million people in China and the Philippines. The latest estima...
Attempts have been made in this dissertation to develop a purified antigen with high sensitivity and...
The schistosome blood flukes are some of the largest global causes of parasitic morbidity. Further s...
Abstract Approximately 200 million people worldwide currently suffer from schistosomiasis, one of th...
Scores of millions of people around the world are infected by Schistosoma mansoni causing considerab...
Background: Schistosomiasis continues to be a significant public health problem. This disease affect...
The development of a more sensitive diagnostic test for schistosomiasis is needed to overcome the li...
INTRODUCTION: The correlation between the immunological assay and the antibody titer can offer a too...
An effective schistosome vaccine is a desirable control tool but progress towards that goal has been...
We have previously confirmed the presence of common antigens between Schistosoma mansoni and its vec...
Background: Schistosomiasis continues to be one of the most prevalent parasitic diseases in the worl...
Three antigens protective against Schistosoma mansoni have been extensively characterized. The schis...
Polypeptide surface antigens of Schistosoma mansoni recognized by schistosomiasis patients have been...
Chronic schistosomiasis is a spectral illness where patients present with either moderate intestinal...
Attempts have been made in this dissertation to develop a purified antigen with high sensitivity and...
Schistosoma japonicum affects several million people in China and the Philippines. The latest estima...
Attempts have been made in this dissertation to develop a purified antigen with high sensitivity and...
The schistosome blood flukes are some of the largest global causes of parasitic morbidity. Further s...
Abstract Approximately 200 million people worldwide currently suffer from schistosomiasis, one of th...
Scores of millions of people around the world are infected by Schistosoma mansoni causing considerab...
Background: Schistosomiasis continues to be a significant public health problem. This disease affect...
The development of a more sensitive diagnostic test for schistosomiasis is needed to overcome the li...
INTRODUCTION: The correlation between the immunological assay and the antibody titer can offer a too...
An effective schistosome vaccine is a desirable control tool but progress towards that goal has been...